医学临床研究
  2025年4月6日 星期日           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2024, Vol. 41 Issue (6): 817-819    DOI: 10.3969/j.issn.1671-7171.2024.06.005
  论著 本期目录 | 过刊浏览 | 高级检索 |
宫腹腔镜联合药物促排卵治疗输卵管性不孕患者的临床效果*
孙海云a, 赵通a, 胡玉宏b, 孟缓缓a, 唐琳a, 毛宝红a**
上海市金山区亭林医院:a.妇产科;b.超声科,上海 201505
Clinical Efficacy of Hysterolaparoscopy Combined with Medication for Ovulation Induction in the Treatment of Tubal Infertility Patients
SUN Haiyun, ZHAO Tong, HU Yuhong,et al
Department of Obstetrics and Gynaecology,Shanghai Jinshan District Tinglin Hospital,Shanghai 201505
全文: PDF (1275 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨宫腹腔镜联合药物促排卵治疗输卵管性不孕患者的临床效果。【方法】选取本院诊治的60例输卵管性不孕患者作为研究对象,按照随机数字表法分为A组(采用宫腹腔镜联合尿促卵泡素治疗)、B组(采用宫腹腔镜联合来曲唑治疗)和C组(采用宫腹腔镜治疗),每组20例。比较两组患者卵巢功能指标、术后受孕时间、妊娠率、流产率、分娩率、畸形胎儿率。【结果】A组、B组、C组治疗后卵巢功能指标雌二醇(E2)、卵泡刺激素(FSH)、促黄体生成素(LH)水平均高于治疗前(P<0.05);A组治疗后LH、FSH、E2水平显著高于B组和C组(P<0.05);B组治疗后LH、FSH、E2水平显著高于C组(P<0.05)。A组、B组、C组妊娠率分别为85.00%、75.00%、55.00%,三组比较,差异有统计学意义(P<0.05)。A组术后受孕时间均短于B组、C组(P<0.05);B组术后受孕时间短于C组(P<0.05)。A组、B组、C组流产率分别为5.88%、6.67%、27.27%,三组比较,差异有统计学意义(P<0.05);A组、B组、C组分娩率分别为94.12%、93.33%、72.73%,三组比较,差异有统计学意义(P<0.05);A组、B组、C组畸形胎儿率分别为0、0、9.09%,三组比较,差异无统计学意义(P>0.05)。【结论】宫腹腔镜联合药物促排卵治疗输卵管性不孕患者,可有效改善卵巢功能,提高妊娠率、分娩率,降低流产率,但相对于来曲唑治疗,宫腹腔镜联合尿促卵泡素治疗方案效果更佳,值得临床推广应用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 不育女(雌)性/治疗输卵管疾病/治疗宫腔镜检查治疗结果    
Abstract:【Objective】To explore the clinical effect of hysterolaparoscopy combined with medication for ovulation induction in the treatment of patients with tubal infertility. 【Methods】 Sixty patients with tubal infertility treated in our hospital were selected as the study subjects. They were randomly divided into Group A(treated with hysterolaparoscopy combined with Urofollitrophin), Group B(treated with hysterolaparoscopy combined with letrozole), and Group C(treated with hysteroscopy) using a random number table method, with 20 cases in each group. Two groups of patients were compared in terms of ovarian function indicators, postoperative pregnancy time, pregnancy rate, miscarriage rate, delivery rate, and abnormal fetal rate.【Results】 After treatment, the levels of ovarian function indicators such as estradiol(E2), follicle stimulating hormone(FSH), and luteinizing hormone(LH) in groups A, B, and C were higher than before treatment(P<0.05); After treatment, the levels of LH, FSH, and E2 in Group A were significantly higher than those in Group B and Group C(P<0.05); After treatment, the levels of LH, FSH, and E2 in Group B were significantly higher than those in Group C(P<0.05). The pregnancy rates of Group A, Group B, and Group C were 85.00%, 75.00%, and 55.00%, respectively. The differences among the three groups were statistically significant(P<0.05). The postoperative conception time in Group A was shorter than that in Group B and Group C(P<0.05); The postoperative conception time in Group B was shorter than that in Group C(P<0.05). The abortion rates of Group A, Group B, and Group C were 5.88%, 6.67%, and 27.27%, respectively. The difference among the three groups was statistically significant(P<0.05); The delivery rates of Group A, Group B, and Group C were 94.12%, 93.33%, and 72.73%, respectively. The differences among the three groups were statistically significant(P<0.05); The rates of abnormal fetuses in Group A, Group B, and Group C were 0, 0, and 9.09%, respectively. There was no statistically significant difference among the three groups(P>0.05).【Conclusion】 The combination of Hysterolaparoscopy and medication for ovulation induction can effectively improve ovarian function, increase pregnancy and delivery rates, and reduce miscarriage rates in patients with tubal infertility. However, compared to letrozole treatment, the combination of hysteroscopy and urinary follicle stimulating hormone treatment is more effective and worthy of clinical promotion and application.
Key wordsInfertility, Female/TH    Fallopian Tube Diseases/TH    Hysteroscopy    Treatment Outcome
收稿日期: 2024-03-22     
中图分类号:  R711.75  
基金资助:*上海市金山区医药卫生科技创新项目(编号:2022-WS-18)
通讯作者: **E-mail:maobaoyun001@126.com   
引用本文:   
孙海云, 赵通, 胡玉宏, 孟缓缓, 唐琳, 毛宝红. 宫腹腔镜联合药物促排卵治疗输卵管性不孕患者的临床效果*[J]. 医学临床研究, 2024, 41(6): 817-819.
SUN Haiyun, ZHAO Tong, HU Yuhong,et al. Clinical Efficacy of Hysterolaparoscopy Combined with Medication for Ovulation Induction in the Treatment of Tubal Infertility Patients. JOURNAL OF CLINICAL RESEARCH, 2024, 41(6): 817-819.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.06.005     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I6/817
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn